Soleus Private Equity Fund III, L.P. → Prelude Therapeutics Inc PRLD

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 3.48

2,822,240 shares short · +57.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $172K

Point72 Asset Mgmt

Other 13D/G Filings on Prelude Therapeutics Inc

Filed	Form	Filer	Stake	Shares
2023-05-24	SC	BAKER BROS. ADVISORS LP	—	—	view →
2023-05-24	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-01-14	SC	ORBIMED ADVISORS LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →